The PTD component of this peptide was specifically designed to solve the delivery problem, making daily topical use practical and non-invasive
However, if the fever is high or persistent, it is important to seek medical advice
In the clinical context, patients are typically instructed to follow this dosing schedule: One subcutaneous injection containing 2 mg tesamorelin daily Taken at the same time each day, ideally before bed Five days per week Continue for 60 days, with one month off Ipamorelin Dosage and Administration In terms of ipamorelin dosage , this peptide has not been approved for human use and therefore has no recommended dosage or cycling structure
Clinical trials and prescribing information also identify common gastrointestinal reactions such as nausea, vomiting, diarrhea, constipation, abdominal pain, bloating, and related symptoms
Hepatology 2005